The turnover of basic pharmaceutical products and pharmaceutical preparations in the Netherlands has seen varying trends over the past decade. Starting from a downturn between 2013 and 2014, the market picked up variably with notable increases in 2015 and 2016. The period from 2017 to 2020 showed stable growth with a significant peak in 2020 likely due to pandemic-related demand. A decline followed in 2021 with a slight recovery in 2022 and 2023, where the market stabilized at 6.44 billion euros. The average annual growth rate over the last 5 years was modest at around 1.39%.
Future trends to watch for:
- Innovation in pharmaceuticals and biotechnology driving market growth.
- Impact of regulatory changes and healthcare reforms.
- Potential effects of global economic conditions on pharmaceutical spending.
